CLINISOL- lysine, leucine, phenylalanine, valine, histidine, isoleucine, methionine, threonine, tryptophan, alanine, arginine, g United States - English - NLM (National Library of Medicine)

clinisol- lysine, leucine, phenylalanine, valine, histidine, isoleucine, methionine, threonine, tryptophan, alanine, arginine, g

baxter healthcare corporation - lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8d - lysine 1.18 g in 100 ml - 15% clinisol - sulfite-free (amino acid) injection pharmacy bulk package is indicated as an adjunct in the offsetting of nitrogen loss or in the treatment of negative nitrogen balance in patients where: (1) the alimentary tract cannot or should not be used, (2) gastrointestinal absorption of protein is impaired, or (3) metabolic requirements for protein are substantially increased, as with extensive burns. hypersensitivity to one or more amino acids severe liver disease or hepatic coma anuria metabolic disorders involving impaired nitrogen utilization

Primene 10% solution for infusion 250ml bottles United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

primene 10% solution for infusion 250ml bottles

baxter healthcare ltd - l-isoleucine; l-leucine; l-valine; l-lysine; l-phenylalanine; l-threonine; tryptophan; l-arginine; l-histidine; l-alanine; l-aspartic acid; l-cysteine; l-glutamic acid; glycine; l-proline; l-serine; l-tyrosine; l-ornithine hydrochloride; taurine; l-methionine - solution for infusion - 6.7gram/1litre ; 10gram/1litre ; 7.6gram/1litre ; 11gram/1litre ; 4.2gram/1litre ; 3.7gram/1litre ; 2gram/1litre ; 8.4gram/1litre ; 3.8gram/1litre ; 8gram/1litre ; 6gram/1litre ; 1.89gram/1litre ; 10gram/1litre ; 4gram/1litre ; 3gram/1litre ; 4gram/1litre ; .45gram/1litre ; 3.18gram/1litre ; .6gram/1litre ; 2.4gram/1litre

Primene 10% solution for infusion 100ml bottles United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

primene 10% solution for infusion 100ml bottles

baxter healthcare ltd - l-leucine; l-valine; l-lysine; l-phenylalanine; l-threonine; tryptophan; l-isoleucine; l-arginine; l-histidine; l-aspartic acid; l-cysteine; l-glutamic acid; glycine; l-proline; l-serine; l-tyrosine; l-ornithine hydrochloride; taurine; l-alanine; l-methionine - solution for infusion - 10gram/1litre ; 7.6gram/1litre ; 11gram/1litre ; 4.2gram/1litre ; 3.7gram/1litre ; 2gram/1litre ; 6.7gram/1litre ; 8.4gram/1litre ; 3.8gram/1litre ; 6gram/1litre ; 1.89gram/1litre ; 10gram/1litre ; 4gram/1litre ; 3gram/1litre ; 4gram/1litre ; .45gram/1litre ; 3.18gram/1litre ; .6gram/1litre ; 8gram/1litre ; 2.4gram/1litre

SYNTHAMIN 17 Amino acid 10% without Electrolytes with Glucose 50% 1000mL injection AHB6998 Australia - English - Department of Health (Therapeutic Goods Administration)

synthamin 17 amino acid 10% without electrolytes with glucose 50% 1000ml injection ahb6998

baxter healthcare pty ltd - methionine, quantity: 2 g/l; valine, quantity: 2.9 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); isoleucine, quantity: 3 g/l; glycine, quantity: 5.15 g/l; tryptophan, quantity: 0.9 g/l; histidine, quantity: 2.4 g/l; alanine, quantity: 10.35 g/l; phenylalanine, quantity: 2.8 g/l; tyrosine, quantity: 200 mg/l; glucose, quantity: 250 g/l; threonine, quantity: 2.1 g/l; arginine, quantity: 5.75 g/l; leucine, quantity: 3.65 g/l; serine, quantity: 2.5 g/l; proline, quantity: 3.4 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; sodium metabisulfite; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

SYNTHAMIN 17 Amino acid 10% with Electrolytes and Glucose 50% 1000mL injection AHB6351 Australia - English - Department of Health (Therapeutic Goods Administration)

synthamin 17 amino acid 10% with electrolytes and glucose 50% 1000ml injection ahb6351

baxter healthcare pty ltd - arginine, quantity: 5.75 g/l; leucine, quantity: 3.65 g/l; sodium chloride, quantity: 0.59 g/l; glycine, quantity: 5.15 g/l; proline, quantity: 3.4 g/l; serine, quantity: 2.5 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); threonine, quantity: 2.1 g/l; glucose, quantity: 250 g/l; alanine, quantity: 10.35 g/l; dibasic potassium phosphate, quantity: 2.61 g/l; tryptophan, quantity: 0.9 g/l; phenylalanine, quantity: 2.8 g/l; histidine, quantity: 2.4 g/l; isoleucine, quantity: 3 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; sodium metabisulfite; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

SYNTHAMIN 17 Amino acid 10% with Electrolytes and Glucose 25% 1000mL injection AHB6350 Australia - English - Department of Health (Therapeutic Goods Administration)

synthamin 17 amino acid 10% with electrolytes and glucose 25% 1000ml injection ahb6350

baxter healthcare pty ltd - dibasic potassium phosphate, quantity: 2.61 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); magnesium chloride hexahydrate, quantity: 0.51 g/l; sodium acetate, quantity: 3.4 g/l; threonine, quantity: 2.1 g/l; isoleucine, quantity: 3 g/l; proline, quantity: 3.4 g/l; glucose, quantity: 125 g/l; alanine, quantity: 10.35 g/l; sodium chloride, quantity: 0.59 g/l; serine, quantity: 2.5 g/l; methionine, quantity: 2 g/l; phenylalanine, quantity: 2.8 g/l; glycine, quantity: 5.15 g/l; - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

AMINOSYN-PF- isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, a United States - English - NLM (National Library of Medicine)

aminosyn-pf- isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, a

hospira, inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), alanine (unii: of5 - aminosyn-pf 10%, sulfite-free, (an amino acid injection — pediatric formula) is indicated for the nutritional support of infants (including those of low birth weight) and young children requiring tpn via either central or peripheral infusion routes. parenteral nutrition with aminosyn-pf 10% is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young children where (1) the alimentary tract by the oral gastrostomy, or jejunostomy route, cannot or should not be used or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutrition support, and vein tolerance. see dosage and administration for additional information. centr

NUTRINEAL PD]4 Peritoneal Dialysis Solution with 1.1% Amino Acids Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nutrineal pd]4 peritoneal dialysis solution with 1.1% amino acids

baxter healthcare (malaysia) sdn. bhd. - sodium lactate; l-isoleucine usp; l-leucine usp; l-phenylalanine usp; l-threonine usp; l-tryptophan usp; l-histidine usp; l-proline usp; l-serine usp; l-valine usp; l-tyrosine usp; l-methionine usp; l-alanine usp; l-arginine usp; l-lysine hci usp; calcium chloride dihydrate usp; sodium chloride, usp; glycine, usp; magnesium chloride hexahydrate usp -

AMINOSYN-PF- isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, a United States - English - NLM (National Library of Medicine)

aminosyn-pf- isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, a

icu medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), alanine (unii: of5 - aminosyn-pf 10%, sulfite-free, (an amino acid injection — pediatric formula) is indicated for the nutritional support of infants (including those of low birth weight) and young children requiring tpn via either central or peripheral infusion routes. parenteral nutrition with aminosyn-pf 10% is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young children where (1) the alimentary tract by the oral gastrostomy, or jejunostomy route, cannot or should not be used or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutrition support, and vein tolerance. see dosage and administration for additional information. centr

TRIOMEL 9G/L Nitrogen 1070KCAL/L, emulsion for infusion Malta - English - Medicines Authority

triomel 9g/l nitrogen 1070kcal/l, emulsion for infusion

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - phenylalanine, histidine, arginine, aspartic acid, olive oil, threonine, tyrosine, valine, glucose monohydrate, glutamic acid, glycine, methionine, isoleucine, tryptophan, lysine, serine, proline, soybean oil - emulsion for infusion - phenylalanine histidine arginine aspartic acid olive oil alanine threonine tyrosine valine glucose monohydrate 250 g glutamic acid glycine methionine isoleucine l-tryptophan lysine serine leucine proline soybean oil - blood substitutes and perfusion solutions